HEALTH TECH 2020 – Horizon 2020 Partnering Event in London
29 Oct 15
On 29-30th October Vision2020, in collaboration with MedCity and Research Media, will be hosting Health Tech 2020 at London City Hall.
On 29-30th October Vision2020, in collaboration with MedCity and Research Media, will be hosting Health Tech 2020 at London City Hall.
LEITAT Foundation, FC Barcelona Foundation and Bioiberica S.A, a biotechnology company specialised in arthritis and health, have joined forces to
LEITAT is boosting a community in the Health’s industries sector about Technologies for Health, which met in Terrassa on the
El proyecto de investigación aplicada ToxAb tiene por objetivo principal generar una ventaja competitiva en el área de la terapia
There is nothing very glamorous about cancer, but now a new EU-funded project – GLAM – aims to help make
During the PEGS 2015, the Toxab project presented a poster about recombinant antibodies for research, diagnosis and therapy. Antibodies are
GLAM Glass-Laser Multiplexed Biosensor glam-project.eu Differential cancer diagnosis takes place daily in clinical settings for a better monitoring of patient
DENECOR Devices for NeuroControl and NeuroRehabilitation www.denecor.info ABSTRACT DeNeCor addresses the diagnosis and treatment of neurological diseases, which have an
Resorbable Ceramic Biocomposites for Orthopaedic and Maxillofacial Applications
This year’s ETP Nanomedicine Event & General Assembly is hosted by CIC NanoGUNE, the Spanish nanoscience cooperative research centre in
The sixth edition of MuscleTech Network Workshop, organized by the Technology Centre LEITAT, FC Barcelona, and Aspetar, is held during
NANO4DERM Nanocapsules containing active substances for the topical treatment of dermatological diseases ABSTRACT The research project Nano4Derm will focus on
Leitat is attending the IMI2 Open Info day in Brussels and taking note of every novelty that the new edition
LEITAT attended the first meeting of Vision 2020 Health Cluster at KU Leuven. The 2-days event aimed at discussing priorities
According to the new release of Health-EU newsletter, since March the Commission has invested more than 11.9 million Euros in
TTPPP Application of the Transmembrane Therapeutic Protein Production Platform (TTPPP) to an innovative approach for the Treatment of Cancer or
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300
